Gencor Announces Receipt of NYSE Regulation Notice Regarding Late Filing of the Quarterly Report on Form 10-Q for the period Ended March 31, 2026
Gencor Industries said it received a NYSE Regulation filing delinquency notice on May 19, 2026 for its late Form 10-Q for the quarter ended March 31, 2026, filed after the May 18 due date. The company is not in compliance with NYSE American listing standards but said the notice has no immediate trading impact. NYSE allows six months to regain compliance by filing; delisting could be initiated if warranted.
How this was made
The 30-second read
Why it matters
The NYSE provides a six-month period from the original due date to regain compliance by filing the 10-Q; failure could lead to an additional discretionary extension or initiation of suspension/delisting proceedings.
Market read
Primary tradable element is the compliance/cure timeline and the probability-weighted risk of a delayed 10-Q leading to suspension/delisting proceedings.
What to watch
Even without immediate trading impact, repeated delays or missed cure periods can trigger suspension/delisting proceedings, which can reprice liquidity and credit risk for the stock.
Background
Gencor missed the May 18, 2026 due date for its quarter ended March 31, 2026 Form 10-Q, prompting an NYSE American filing delinquency notification.
Ticker impact
Gencor received an NYSE Regulation delinquency notice for late filing its March 31, 2026 10-Q, risking noncompliance and potential suspension/delisting.
Bias toward downside/volatility into the next filing deadline window; larger move possible if the 10-Q is delayed beyond the stated period.
The notice flags continued listing standards risk, yet explicitly states no immediate effect on trading; the main catalyst is whether the company files within the NYSE’s six-month cure period.
Market effects
Limited sector read-across; this is company-specific exchange compliance rather than an industry fundamental shock.
None indicated beyond the issuer’s own listing status risk.
Low; the event is NYSE American procedural compliance with no direct global macro linkage.
Counterpoint
Because NYSE states there is no immediate effect on trading, the market may treat this as administrative and fade the risk if the 10-Q is filed on time.
Key entities
- companyGencor Industries, Inc.
Issuer that received the NYSE Regulation delinquency notification for late 10-Q filing.
- regulatorNYSE Regulation
Entity issuing the delinquency notification under NYSE American listing rules.
- exchangeNYSE American LLC
Exchange whose continued listing standards are at issue and whose cure procedures apply.
- regulatorSEC
Receives the Form 10-Q filing that would cure the delinquency.
